Specialty Biocides - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The specialty biocides market was valued at USD 13.32 billion in 2025 and is estimated to grow from USD 13.97 billion in 2026 to reach USD 18.72 billion by 2031, at a CAGR of 6.03% during the forecast period (2026-2031). This report is Segmented by Biocide Type (Non-Oxidizing Biocides and Oxidizing Biocides), Product Type (Halogen-Based Biocides, Organosulfur Biocides, and More), Application (Industrial Water Treatment, Oil and Gas, Pulp and Paper, and More), and Geography (Asia-Pacific, North America, Europe, South America, and Middle-East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Global Specialty Biocides Market Trends and Insights

Increasing Demand for Water Reuse and Compliance with Industrial Wastewater Regulations

Industrial effluent rules and water recycling requirements are strengthening demand for specialty biocides. The US Environmental Protection Agency (EPA) industrial zero liquid discharge water reuse rule took effect on July 16, 2026, and expanded monitoring for micropollutants, including per- and polyfluoroalkyl substances (PFAS) precursors and nanosilver residues. A July 2026 European Chemicals Agency (ECHA) restriction affecting phosphite-containing reverse osmosis antiscalants, which raises interest in non-chlorine active systems. Tetrakis(hydroxymethyl)phosphonium sulfate (THPS), 2,2-dibromo-3-nitrilopropionamide (DBNPA), and peracetic acid systems are suited to zero liquid discharge and reverse osmosis pretreatment because they can reduce membrane fouling concerns. Demand in the specialty biocides market, therefore, remains linked to compliance needs even when treated water volumes do not rise.

Growing Demand for Institutional Hygiene and Infection Control Solutions

Healthcare-associated infections continue to support institutional demand for effective surface disinfection in the specialty biocides market. The World Health Organization reported that healthcare-associated infections affect one in ten patients in high-income countries and 1 in 4 patients in low- and middle-income countries at any given time. Quaternary ammonium compounds remain important because they are effective against common hospital pathogens, including multidrug-resistant Klebsiella pneumoniae and Acinetobacter baumannii. A 2025 review identified gaps in standardized biocide susceptibility testing, which can complicate resistance surveillance and future stewardship measures. Arxada announced a June 2026 agreement with Clorox Healthcare to introduce its EPA-registered Quanticare sporicidal technology in North American healthcare facilities. Hospital procurement requirements for EPA Safer Choice-certified products can favor suppliers with established compliance credentials.

Stringent Toxicological and Environmental Regulations Governing Active Biocidal Substances

Active-substance reviews can slow product approvals and increase compliance costs across the specialty biocides market, especially in Europe. The Biocidal Products Regulation reviews can take 5-10 years for an active substance. Joint ECHA and European Food Safety Authority (EFSA) guidance applies to biocide applications submitted from April 1, 2026, and requires review of transformation products under realistic drinking-water treatment conditions. The required assessment covers byproducts from processes such as chlorination and ozonation. EU Implementing Regulation 2026/1331 took effect on June 4, 2026 and changed administrative and compliance requirements for authorized calcium hypochlorite biocides. Large suppliers can spread dossier-development costs across broader portfolios, while smaller regional firms face a heavier burden.

Other drivers and restraints analyzed in the detailed report include:

• Increasing Use of Specialty Biocides in Oilfield Water Management and Asset Protection
• Advancements in In-Situ Biocide Generation and Digital Biocide Dosing Technologies
• Increasing Concerns Regarding Microbial Resistance and Reduced Biocide Effectiveness

Segment Analysis

Non-oxidizing biocides held 62.34% of the specialty biocides market share in 2025. Their position in the specialty biocides market reflects compatibility with reverse osmosis pretreatment, produced-water reuse, and cooling-tower systems. These systems can be damaged by oxidizing actives, which gives non-oxidizing products a practical role in membrane-intensive operations. THPS and DBNPA are used widely in oilfield applications. Isothiazolinone formulations, including MIT, CMIT, and BIT, are used in in-can preservation and cooling-water programs across manufacturing. Organosulfur and aldehyde-based biocides, including glutaraldehyde, serve similar needs but face regulatory pressure in some jurisdictions.

Plant-derived alternatives could become more relevant within this specialty biocides market segment during 2026-2031. A 2025 review found that these alternatives achieved 80-99.8% inhibition efficiency in relevant applications. This performance creates room for lower-toxicity active systems where conventional chemistries face review. Oxidizing biocides are forecast to grow at a 6.72% CAGR through 2031. In-situ generation and demand for sporicidal healthcare disinfection support that growth. EN 18087:2026 supports chlorine dioxide generation systems, while Arxada introduced a patented on-site peracetic acid generation technology in October 2025.

Complete Report Scope:

• By Biocide Type
  • Non-Oxidizing Biocides
  • Oxidizing Biocides
• By Product Type
  • Halogen-Based Biocides
  • Organosulfur Biocides
  • Quaternary Ammonium Compounds (Quats)
  • Aldehyde Biocides
  • Phenolic Biocides
  • Organic Acid Biocides
  • Metallic Biocides
  • Other Specialty Biocides
• By Application
  • Industrial Water Treatment
  • Oil and Gas
  • Pulp and Paper
  • Personal Care and Cosmetics
  • Healthcare
  • Paints and Coatings
  • Food and Beverage Processing
  • Other Applications
• By Geography
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle-East and Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle-East and Africa

Geography Analysis

Asia-Pacific held 41.66% of global revenue in 2025, making it the largest regional specialty biocides market. China’s contribution is supported by water treatment demand and movement toward non-chlorine actives under absorbable organic halogen discharge requirements. India’s demand is supported by wastewater compliance needs in pharmaceutical, textile, and food-processing clusters. THOR China opened a Benzisothiazolinone (BIT) plant in Zhenjiang, Jiangsu, in January 2025. The facility includes a solvent-recycling process and is intended to expand production and service capacity in the Asia-Pacific.

North America has a mature but active demand base in the specialty biocides market, supported by water reuse requirements, power and chemical processing, and healthcare investment. US demand benefits from high-purity formulations and digital dosing services supplied by Ecolab, Solenis, and Kemira. These offerings can obtain premium pricing compared with commodity supplies. Europe has the most demanding compliance setting because of the EU Biocidal Products Regulation. Suppliers can use that regulatory experience when serving less-regulated export markets.

South America is an emerging demand center in the specialty biocides market, with Brazil supporting municipal water treatment and food and beverage processing. Argentina’s Vaca Muerta development supports demand for oilfield microbial control. An SPE paper described a tailored solution for Halanaerobium microorganisms in Argentine unconventional operations. This work shows why local microbial conditions can require customized programs. The Middle-East and Africa are supported by oilfield water management in the Arabian Gulf and growing desalination capacity in Saudi Arabia and the UAE. Biocides are used to manage biological fouling in multi-stage flash and reverse osmosis desalination systems.

List of Companies Covered in this Report:

• Accepta Ltd.
• Arxada AG
• Baker Hughes Company
• BASF
• Clariant
• Dow
• Ecolab Inc.
• Kemira Oyj
• Lanxess
• Neogen Corporation
• Nouryon
• Solenis
• Thor Group Limited
• Troy Corporation
• Veolia Water Technologies

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support